Every acquisition rationale that survives contact with a skeptical board reduces, eventually, to one of a small number of families. Learn them cold. They're the vocabulary you'll use to answer "why this deal?" A rationale that doesn't fit cleanly into one of them is itself a warning sign, and so is one that borrows a little from several without committing to any.
When do scale and vertical integration justify a deal?
Horizontal consolidation / scale. Buy a competitor in the same market to gain share, spread fixed costs over more volume, and concentrate procurement leverage. This is the classic roll-up logic, and its synergies are mostly the credible, cost-side kind you'll meet on the M&A synergies page. But scale bought this way raises market share in a single stroke. Competition regulators (India's CCI, the US DOJ/FTC) are built to scrutinize that kind of jump. A rationale that is entirely "we get bigger", with no second-order benefit such as better unit economics or a stronger competitive position, is thin.
Vertical integration. Buy a supplier (backward) to capture margin and secure a critical input, or a customer/channel (forward) to control distribution, pricing, or the end-customer relationship. The logic is real, because control over a chokepoint is valuable. But the buyer is now operating a business with a different economic model and a different skill set from its own. A steel maker that buys an iron-ore mine hasn't bought "more steel." It has bought a mining company. So the rationale has to survive one question: do we actually have, or can we credibly hire, the capability to run this?
Advertisement
When do capability and market access rationales hold up?
Capability / technology acquisition. Buy speed. A target's technology, patent position, or specialist team would take years to build organically, and the market won't wait. This rationale holds up to the extent the buyer admits it is buying a team and a capability, and not a revenue stream. Watch for the moment the case starts leaning on the target's current P&L instead of on what the combined entity can do with the capability. At that point the rationale has drifted into a synergy story, and that story belongs in the M&A synergies page. The deeper question (build this capability, buy it, or partner for it) gets its full treatment when you reach portfolio strategy and build-buy-partner.
Here you're evaluating a "buy" that has already been chosen as the mode.
Market access / geographic expansion. Buy a local player for its distribution network, regulatory licenses, or brand trust, because organic entry would take too long or cost too much relative to buying an incumbent's head start. It's strong when the target's local assets are hard to replicate, like a licensed distribution network or an entrenched brand. It's weak when the "access" being bought is simply a headcount of salespeople the buyer could have hired directly at a fraction of the control premium.
Why is diversification the weakest rationale?
Diversification. The weakest rationale family, and the one that should trigger the most scrutiny by default. Its test is simple, and it's almost always fatal to a pure diversification story. A public-market shareholder can diversify her own portfolio far more cheaply (with full liquidity and no control premium) than a company can diversify by buying an unrelated business. So for a diversifying acquisition to survive, the acquirer must show a specific, company-level advantage that a shareholder lacks: a transferable capability, a financing-cost edge, or unique access to a distressed asset. Absent one of those, "diversification" is a euphemism for empire-building. It shows up later as the conglomerate/holding-company discount the market applies to this pattern (covered in the special-situations work on sum-of-the-parts).
What about defensive consolidation and roll-ups?
Defensive consolidation. Buy an asset to keep a competitor from getting it, or to avoid becoming a target yourself by growing scale. It's a real and sometimes correct motive. It's also the rationale most prone to self-justifying escalation. From the outside, "we had to have it" looks the same as ordinary auction fever (more on that on the M&A red flags page), and your job as the advisor is to tell the two apart.
Talent (acqui-hire) and roll-up/platform strategy. Buying a small team purely for its people, or (the private-equity-style pattern) buying a platform and then bolting on many small, similar targets at a repeatable playbook. Roll-ups live and die on multiple arbitrage: buying at a lower multiple than the platform trades at. The M&A lab handles the mechanics of that arithmetic. It also covers the cheap-currency trap of confusing "accretive" with "value-creating" when you arbitrage multiples this way.
Your advisory question is simpler. Is the platform's operating playbook proven enough to bear repeating, or is each new bolt-on really its own unproven bet dressed up as "more of the same"?